Carly Kenselaar

Item: Carly Kenselaar
Rating: 3.03
Author: StockAnalysis.com

Stock Analyst at Citigroup

(3.03)

# 1,345

Out of 4,960 analysts

Total ratings

83.33%

Success rate

51.18%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$150.49	+16.96%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$17.92	+78.57%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $150.49

Upside: +16.96%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $17.92

Upside: +78.57%